Literature DB >> 8032525

Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.

Y Suzuki1, G Tamura, C Maesawa, T Fujioka, T Kubo, R Satodate.   

Abstract

Very frequent loss of heterozygosity (LOH) on chromosome 3p has been found in human renal cell carcinoma (RCC). In the present study, we examined LOH at the retinoblastoma (RB), mutated in colorectal cancer (MCC) and adenomatous polyposis coli (APC) tumour suppressor genes loci, and mutations of the H-, K-, and N-ras oncogenes. We performed these studies using the polymerase chain reaction (PCR) method followed by restriction fragment length polymorphism (RFLP) and single-strand conformation polymorphism (SSCP) analyses. LOH was detected in 2 of 11 (18.2%), and 2 of 14 (14.3%) informative cases at the MCC and APC loci, respectively, and in none of 15 informative cases at the RB locus in 25 RCCs. LOH at the MCC was accompanied by LOH at the APC locus in two RCCs. No mutation was detected in H-, K-, and N-ras genes in 39 RCCs. Thus, alterations of the known tumour suppressor genes and the ras oncogenes were infrequent events in RCC. The results suggest that the genetic pathway in the genesis of RCC differs considerably from that of other common human carcinomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032525

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  39 in total

1.  Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium.

Authors:  H Mizuuchi; S Nasim; R Kudo; S G Silverberg; S Greenhouse; C T Garrett
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

2.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

3.  Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

Authors:  S Rodenhuis; M L van de Wetering; W J Mooi; S G Evers; N van Zandwijk; J L Bos
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

5.  Specific chromosome aberration in human renal cell carcinoma.

Authors:  G Kovacs; S Szücs; W De Riese; H Baumgärtel
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

6.  Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma.

Authors:  T Uchida; C Wada; T Shitara; S Egawa; S Mashimo; K Koshiba
Journal:  J Urol       Date:  1993-10       Impact factor: 7.450

7.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

Authors:  Y Murakami; K Hayashi; S Hirohashi; T Sekiya
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

8.  Expression of cellular oncogenes in human malignancies.

Authors:  D J Slamon; J B deKernion; I M Verma; M J Cline
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

9.  Activated H-ras oncogenes in human kidney tumors.

Authors:  J Fujita; M H Kraus; H Onoue; S K Srivastava; Y Ebi; Y Kitamura; J S Rhim
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

10.  Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci.

Authors:  G Tamura; C Maesawa; Y Suzuki; S Ogasawara; M Terashima; K Saito; R Satodate
Journal:  Jpn J Cancer Res       Date:  1993-10
View more
  3 in total

1.  Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.

Authors:  Teppei Matsuo; Satoshi S Nishizuka; Kazushige Ishida; Takeshi Iwaya; Miyuki Ikeda; Go Wakabayashi
Journal:  BMC Res Notes       Date:  2011-05-10

Review 2.  Wnt signaling pathways in urological cancers: past decades and still growing.

Authors:  Shahana Majid; Sharanjot Saini; Rajvir Dahiya
Journal:  Mol Cancer       Date:  2012-02-10       Impact factor: 27.401

3.  Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.

Authors:  Y Nishiyama; H Suwa; K Okamoto; M Fukumoto; H Hiai; S Toyokuni
Journal:  Jpn J Cancer Res       Date:  1995-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.